Full text
| |
| Author(s): |
Matheus Levi Tajra Feitosa
Total Authors: 1
|
| Document type: | Doctoral Thesis |
| Press: | São Paulo. |
| Institution: | Universidade de São Paulo (USP). Faculdade de Medicina Veterinária e Zootecnia (FMVZ/SBD) |
| Defense date: | 2011-12-06 |
| Examining board members: |
Carlos Eduardo Ambrósio;
Antônio Chaves de Assís Neto;
Paula Fratini;
Silvio Henrique de Freitas;
Angelo João Stopiglia
|
| Advisor: | Carlos Eduardo Ambrósio; Maria Angélica Miglino |
| Abstract | |
The regeneration of damaged nerve cells of the central nervous system (CNS) is limited due to factors intrinsic to the own cell niche. The glial scar, the release of axonal growth inhibitors, and the phagocytic action of astrocytes are factors that limit this regeneration, deterring axonal restructuring. The spinal cord injuries cause a great impact on the lives of sufferers and their families. The use of stem cells has emerged as a viable alternative to the treatment of spinal cord injuries in humans and animals. However, despite attempts therapies in animals show encouraging results, clinical trials performed in humans require further study, and have not had satisfactory results. This paper proposed the clinical use of stem cells from human dental pulp in dogs with chronic spinal cord injury, and the use of stem cells from the rabbit olfactory epithelium in rabbits with spinal cord injury induced by dorsal hemisection. Three dogs underwent surgery and evaluated by behavioral test and magnetic resonance imaging. Six rabbits underwent surgical technique for spinal cord dorsal hemisection and were transplanted with stem cells from the olfactory epithelium of rabbits and evaluated by histology and immunohistochemistry. Stem cells of the olfactory epithelium of rabbits were traced in the spinal cord of animals 20 days after the completion of cell therapy, confirming the success of transplantation. Green fluorescent protein (GFP) tracked by immunohistochemical evidence the success of cell transplantation. The canine clinical case one presented a marked clinical improvement, jumping from a score of 4 to a score of 8 in a short time, but there was no improvement in magnetic resonance imaging. The canine clinical case two showed clinical improvement, although the MRI showed a worsening situation in the spinal cord. And our canine clinical case 3 showed minimal clinical improvement, no change in image pre-and postoperatively. The data obtained from this study show that cell therapy with stem cells in spinal cord injury may be beneficial, but still not a cure for chronic spinal cord injuries. (AU) | |